How do I transition from active treatment to surveillance for Melanoma

Transitioning from Active Treatment to Surveillance for Melanoma

This is an important question, and the transition to surveillance (also called follow-up care) is a significant milestone in your melanoma journey. Let me explain how this typically works based on current medical guidelines.

When Does Surveillance Begin?

According to the NCCN Guidelines for Patients: Melanoma (2025), the timing of your transition to surveillance depends on your specific situation:

After Surgery Alone (Early-Stage Melanoma):

• If you had surgery to remove your melanoma and there's no evidence of disease, you move directly into surveillance/follow-up care

After Systemic Therapy (Immunotherapy or Targeted Therapy):

• If you received treatments like nivolumab, pembrolizumab, or dabrafenib/trametinib, your doctor will perform imaging and possibly biopsies to confirm there's no remaining cancer
• Once "no evidence of disease" is confirmed, you transition to surveillance

After T-VEC or Other Local Treatments:

• Similar process—your care team will assess response through exams and imaging before moving to surveillance

What Surveillance Actually Involves

The NCCN Guidelines emphasize that surveillance is active monitoring, not passive waiting. Here's what to expect:

Clinical Exams by Your Doctor:

• Your provider will examine your skin and lymph nodes regularly
• How often depends on your melanoma stage and risk of recurrence
• Many patients have exams at least once every year, though some may need more frequent visits initially

Self-Examinations:

• You'll learn to perform regular skin self-exams using the ABCDE rule to catch any changes early:
  • Asymmetry – one half doesn't match the other
  • Border – irregular, hard-to-define edges
  • Color – not uniform throughout
  • Diameter – larger than a pencil eraser (6mm)
  • Evolving – changes in size, shape, or color over time

Imaging and Testing:

• Your doctor may use imaging tests (like CT or PET scans) based on your stage and risk factors
• If you had lymph node involvement, your doctor might consider more imaging
• Genetic testing may be discussed if there's a family history of cancer

Important Transition Conversations

Before you finish active treatment, ask your care team these specific questions:

1. "Based on my stage and treatment, how often should I have follow-up appointments?"

   • This helps you understand your personalized surveillance schedule

2. "What imaging tests, if any, will I need during surveillance?"

   • Different stages require different monitoring approaches

3. "How should I perform skin self-exams, and what changes should I report immediately?"

   • Getting clear instructions now prevents confusion later

4. "What are the signs of recurrence I should watch for?"

   • Knowing what to look for empowers you to catch problems early

5. "Will I need genetic counseling or testing?"

   • Important if you have a family history of melanoma or other cancers

The Emotional Transition

Moving from active treatment to surveillance can feel both relieving and anxiety-provoking. This is completely normal. You're shifting from frequent appointments and clear treatment plans to a monitoring phase where you have more responsibility for self-awareness. Many patients find it helpful to:

• Mark surveillance appointments on your calendar in advance
• Keep a record of any skin changes between visits
• Connect with melanoma support groups (the NCCN Guidelines recommend resources like AIM at Melanoma and the Melanoma Research Foundation)

Key Takeaway

According to the NCCN Guidelines for Patients: Melanoma, surveillance is not a passive phase—it's an active partnership between you and your care team to catch any recurrence as early as possible. Early detection of recurrent melanoma significantly improves treatment outcomes.

Your oncologist or dermatologist will determine the most appropriate surveillance schedule and testing for YOUR specific case based on your complete clinical picture, including your melanoma stage, depth, and any other risk factors.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.